Pharmaceutical composition for antagonizing CCR5 comprising anilide derivative
US6268354A · kind A · utility
28Cited by
1References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 13, 2000 |
| Grant date | Jul 31, 2001 |
| Priority date | — |
| Expiry date | Sep 13, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2602/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention is to provide a pharmaceutical composition for antagonizing CCR5 which comprises a compound of the formula: ##STR1## wherein R.sup.1 is an optionally substituted 5- to 6-membered ring; W is a divalent group of the formula: ##STR2## wherein the ring A is an optionally substituted 5- to 6-membered aromatic ring, X is an optionally substituted C, N or O atom, and the ring B is an optionally substituted 5- to 7-membered ring; Z is a chemical bond or a divalent group; R.sup.2 is (1) an optionally substituted amino group in which a nitrogen atom may form a quaternary ammonium, etc., or a salt thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.